Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05549479
Other study ID # JST-3
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date September 30, 2024

Study information

Verified date October 2023
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: By 2030, 23% of Canadians will be over 65 years of age. Two in five of these individuals will be diagnosed with cancer. Older adults have high levels of functional decline, and a cancer diagnosis adds prolonged physical sequelae to the natural aging process. Many of these effects can be mitigated by regular exercise. However, older adult cancer survivors are significantly less likely to meet current exercise guidelines than their younger counterparts. As our population ages, we need to develop effective, scalable interventions that support health in older adult cancer survivors. The objective of this study is to determine the feasibility and preliminary effectiveness of a virtually delivered peer exercise intervention with qualified exercise professional (QEP) support for older adult cancer survivors. Methods: Participants will include older adult cancer survivors who are cleared for exercise, have consistent access to the internet, and currently take part in less than 150 minutes of exercise per week. All participants will be matched with a partner, given a peer support guide, and information on current exercise guidelines. In addition to being matched with a peer, dyads in the intervention group will have weekly virtual sessions with a QEP for 10 weeks. Participants in the control group will independently support their partner around exercise for 10 weeks. Outcomes: Participants will be assessed at 3 time points. The primary outcome is feasibility. This will be measured by assessing recruitment, retention, adherence rates to the intervention, and participant acceptability and satisfaction. Secondary effectiveness outcomes include exercise volume, social support, quality of life, physical function, and physical activity enjoyment. Impact: If effective, this will be the first virtual peer-based exercise intervention for older adult cancer survivors. Findings will inform future methods aimed at increasing exercise in older adults.


Description:

METHODS Research Questions: Research Question 1 (primary). Is a virtually-delivered, peer matching exercise intervention supported by qualified exercise professionals (QEP) feasible for older adult cancer survivors? Research Question 2. Do older adult cancer survivors who participate in a virtually-delivered peer matching exercise intervention with QEP support have improved levels of social support compared to those matched with a peer only? Research Question 3. Do older adult cancer survivors who participate in a virtually-delivered peer matching exercise intervention with QEP support have improved levels of physical activity behaviour, health-related quality of life and physical functioning compared to those who are matched with a peer only? Study Design: This is a two-arm pilot randomized controlled trial with blinded outcome assessment. The protocol and study methods adhere to the CONSORT extension for randomized pilot trials. The Hamilton Integrated Research Ethics Board will approve this study. Dyads will be randomized (1:1) to the Intervention (AgeMatchPLUS) or control (AgeMatch) groups prior to baseline assessment. Group allocation will be centrally randomized using a web platform (https://www.randomizer.org/) by a graduate student external to the research team. A Research Assistant will assign group allocation in the order participants complete an initial demographics questionnaire and are matched with a peer for the study. Intervention: Peer Matching. A Research Assistant will match all participants into dyads based on evidence-informed criteria. To be matched, females must be in the same time zone and diagnosed with the same type of cancer. Matched peers will be introduced to each other by a Research Assistant via zoom after baseline data collection. All participants will be given a peer support guide that provides tips for supporting their exercise partner, an infographic on exercise guidelines for older cancer survivors and a Fitbit Inspire 2©. Partners will independently communicate and support each other around exercise for the duration of the study. Intervention Group (AgeMatchPLUS). This group will have dyads participate in weekly virtual sessions with a QEP for 10 weeks. Each session will last up to 1 hour. The QEP (i.e., registered kinesiologist) will provide a tailored exercise program, focusing on aerobic activity with both participants in the dyad based on personal circumstances, cancer-related characteristics, side effects, current fitness level, and personal preferences. Overall, content discussed at the sessions will include a review of the exercise program, barriers to exercise participation, achievement of goals, and adverse events. For four weeks following the 10-week intervention, the QEP will be available for consultation (labelled "tapering" period) as needed by participants in this group. This tapering period is important to understand strategies to successfully taper older adults from an exercise trial. Also, during the tapering period, participants in this group will receive two supportive emails from the QEP encouraging ongoing maintenance of exercise and social support. Control Condition (AgeMatch): Dyads in this group will independently communicate and support each other around exercise for 10 weeks. They will not have contact with the QEP during the intervention or tapering period and will structure their communication (mode and frequency) with their matched peer.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 18
Est. completion date September 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - English speaking - Older adult (>60 years) - Living with or beyond a cancer diagnosis (any type or stage of cancer at any stage of treatment) - Living in Canada - Medically cleared for exercise - Have consistent access to an internet-connected device with webcam - Currently take part in less than 150 minutes of MVPA per week Exclusion Criteria: - Self-report any contraindications to exercise - Had recent (in the last 4 weeks) or have planned surgery of any kind (including reconstructive surgery) in the next 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Peer Matching
Participants will be matched with a peer based on evidence informed criteria. Partners will independently communicate and support each other around exercise for the duration of the study.
Qualified Exercise Professional Support Sessions
Dyads will participate in weekly virtual sessions with a QEP for 10 weeks. Each session will last up to 1 hour. The QEP (i.e., registered kinesiologist) will provide a tailored exercise program, focusing on aerobic activity for both individuals in the dyad based on personal circumstances, cancer-related characteristics, side effects, current fitness level (consistent with home-based exercise strategies), and personal preferences.

Locations

Country Name City State
Canada McMaster University Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment rate The percentage of eligible individuals who expressed interest in the study that enrolled 10 weeks
Primary Retention rate The percentage of enrolled participants who completed the intervention 10 weeks
Primary Adherence rate The percentage of total sessions attended and tracked using weekly logs 10 weeks
Primary Participant Satisfaction 7 points Likert satisfaction scale 10 weeks
Secondary Exercise volume Fitbit Inspire 10 weeks
Secondary Exercise volume Fitbit Inspire 14 weeks
Secondary Exercise volume Godin Leisure Time Exercise Questionnaire (higher scores represent higher volume of exercise) 10 weeks
Secondary Exercise volume Godin Leisure Time Exercise Questionnaire (higher scores represent higher volume of exercise) 14 weeks
Secondary Social support Social Support Survey (0-7 scale; higher scores indicate higher levels of social support) 10 weeks
Secondary Social support Social Support Survey (0-7 scale; higher scores indicate higher levels of social support) 14 weeks
Secondary Health-related quality of life Eq-5d-3L (5 dimensions each with a 3 level scale; lower scores indicate higher levels of quality of life) 10 weeks
Secondary Health-related quality of life Eq-5d-3L (5 dimensions each with a 3 level scale; lower scores indicate higher levels of quality of life) 14 weeks
Secondary Self-report physical functioning Patient Specific Functional Scale (10 point scale; higher scores represent higher quality of life) 10 weeks
Secondary Self-report physical functioning Patient Specific Functional Scale (10 point scale; higher scores represent higher quality of life) 14 weeks
Secondary Sub-max aerobic capacity Six minute walk test 10 weeks
Secondary Sub-max aerobic Capacity Six minute walk test 14 weeks
Secondary Physical functioning 30 second sit to stand 10 weeks
Secondary Physical functioning 30 second sit to stand 14 weeks
Secondary Enjoyment of performing physical activity Physical Activity Enjoyment Scale (7 point scale for each item; higher overall scores indicate higher enjoyment of physical activity) 10 weeks
Secondary Enjoyment of performing physical activity Physical Activity Enjoyment Scale (7 point scale for each item; higher overall scores indicate higher enjoyment of physical activity) 14 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients